Fundamental dimension Equity attribute | BIOCQPeer $0.00030.00% Cap $788P/E -0.0x QuantScore52/100 | BSPMLeader $0.00010.00% Cap $264P/E -0.0x QuantScore54/100 | CRFTFPeer $0.000.00% Cap $23P/E -0.0x QuantScore37/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
94/100 |
83/100 |
57/100 |
Valuation Multiples, PEG & DCF upside | 50/100 | 67/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 44/100 | 33/100 | 23/100 |
Growth Revenue / earnings growth & margins | 20/100 | 34/100 | 33/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -0.0x | -0.0x |
Forward P/E (next FY) | -0.0x | — | — |
EV / EBITDA (TTM) | 0.0x | -1.3x | -17.8x |
Price / Sales | 0.0x | 0.0x | 0.0x |
Price / Free Cash Flow | -0.0x | 0.0x | -0.0x |
PEG ratio | 0.00 | -0.00 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | — | 4 / 9 | 3 / 9 |
Altman Z-Score | — | 0.02 (Distress) | -892.96 (Distress) |
Total debt / equity | 1.37 | 0.06 | -0.78 |
Quick ratio | 2.8x | 1.3x | 0.0x |
Interest coverage | -101.2x | -17.3x | -2.9x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -57.8% | -91.2% | -92.3% |
Net income growth YoY | -1036.2% | +77.3% | +87.0% |
Gross margin (TTM) | -10.0% | 38.4% | 5.8% |
Operating margin (FY) | -123.7% | -149.5% | -2137.2% |
FCF margin (FY) | -54.5% | 206.1% | -720.6% |
5. Trailing price performancePrice change over period |
1M return | +50.0% | +0.0% | 0.0% |
3M return | +200.0% | +0.0% | 0.0% |
6M return | +200.0% | +0.0% | 0.0% |
Year to date | +200.0% | +0.0% | 0.0% |
1Y return | +200.0% | +0.0% | 0.0% |
3Y return | -99.9% | 0.0% | -97.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-7,141.70 -2380567319.0% premium | $0.1372 +137133.3% upside | $-2.61 -26104170.2% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |